Osmind Announces Publication of the Largest Real-World Analysis of Ketamine Infusion Therapy for Depression

SAN FRANCISCO--(BUSINESS WIRE)-- #ehr--Osmind, a healthcare technology company and Public Benefit Corporation (PBC) dedicated to empowering clinicians and researchers to bring innovative mental health treatments to those who need it most, today announced the publication of a pivotal peer-reviewed article on real-world ketamine intravenous therapy (KIT). The study, conducted with...

Click to view original post